πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8257932

Interfacing nanostructures to biological cells

The Regents of the University of California Β· Granted Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8227246

Compositions of adult disc stem cells for the treatment of degenerative disc disease

DiscGenics, Inc. Β· Granted Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8211422

Chimeric receptor genes and cells transformed therewith

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173123

Methods of treating colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8163709

TAK1-D mediated induction of cell death in human cancer cells by specific sequence short d

The Board of Regents of the University of Texas System Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153426

Preparation of antigen-presenting human gamma-delta T cells and use in immunotherapy

University College Cardiff Consultants Limited Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8147845

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119398

Adipose-derived stem cells for tissue regeneration and wound healing

PrimeGen Biotech LLC Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114406

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110554

Peptides whose uptake by cells is controllable

The Regents of the University of California Β· Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101159

In vivo methods of identifying compounds which target suppressed cancer cells

The Board of Regents of the University of Oklahoma Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8075881

Use of multipotent adult stem cells in treatment of myocardial infarction and congestive h

Regents of the University of Minnesota Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8075921

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076451

Selective delivery of molecules into cells or marking of cells in diseased tissue regions

Board of Governors for Higher Education, State of Rhode Island and Providence Plantations Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8075920

Administration of cells and cellular extracts for rejuvenation

REGENICS AS Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058063

Method of producing region-specific neurons from human neuronal stem cells

The Board of Regents of the University of Texas System Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8043853

Postnatal gut neural crest stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044259

Determining the capability of a test compound to affect solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034329

Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells

Advanced Technologies and Regenerative Medicine, LLC Β· Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003091

Pharmaceutical compositions comprising purified intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7985887

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. Β· Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7985401

Peptides whose uptake by cells is controllable

The Regents of the University of California Β· Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7964187

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7959934

Method for rapid generation of mature dendritic cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted